4.7 Article

Genistein alleviates pressure overload-induced cardiac dysfunction and interstitial fibrosis in mice

期刊

BRITISH JOURNAL OF PHARMACOLOGY
卷 172, 期 23, 页码 5559-5572

出版社

WILEY
DOI: 10.1111/bph.13002

关键词

-

资金

  1. National Natural Science Foundation of China [81421063, 81230081]
  2. National Nature Science Foundation of China [81270042, 30901208]
  3. Specialized Research Fund for the Doctoral Program of Higher Education [20112307130004]
  4. Program for New Century Excellent Talents In Heilongjiang Provincial University [1254-NCET-01]

向作者/读者索取更多资源

Background and PurposePressure overload-induced cardiac interstitial fibrosis is viewed as a major cause of heart failure in patients with hypertension or aorta atherosclerosis. The purpose of this study was to investigate the effects and the underlying mechanisms of genistein, a natural phytoestrogen found in soy bean extract, on pressure overload-induced cardiac fibrosis. Experimental ApproachGenisten was administered to mice with pressure overload induced by transverse aortic constriction. Eight weeks later, its effects on cardiac dysfunction, hypertrophy and fibrosis were determined. Its effects on proliferation, collagen production and myofibroblast transformation of cardiac fibroblasts (CFs) and the signalling pathways were also assessed in vitro. Key ResultsPressure overload-induced cardiac dysfunction, hypertrophy and fibrosis were markedly attenuated by genistein. In cultured CFs, genistein inhibited TGF1-induced proliferation, collagen production and myofibroblast transformation. Genistein suppressed TGF-activated kinase 1 (TAK1) expression and produced anti-fibrotic effects by blocking the TAK1/MKK4/JNK pathway. Further analysis indicated that it up-regulated oestrogen-dependent expression of metastasis-associated gene 3 (MTA3), which was found to be a negative regulator of TAK1. Silencing MTA3 by siRNA, or inhibiting the activity of the MTA3-NuRD complex with trichostatin A, abolished genistein's anti-fibrotic effects. Conclusions and ImplicationsGenistein improved cardiac function and inhibited cardiac fibrosis in response to pressure overload. The underlying mechanism may involve regulation of the MTA3/TAK1/MKK4/JNK signalling pathway. Genistein may have potential as a novel agent for prevention and therapy of cardiac disorders associated with fibrosis. Linked ArticlesThis article is part of a themed section on Chinese Innovation in Cardiovascular Drug Discovery. To view the other articles in this section visit http://dx. doi. org/10.1111/bph. 2015.172. issue-23

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据